Skip to main content
. 2021 Jun 17;12:693725. doi: 10.3389/fmicb.2021.693725

FIGURE 4.

FIGURE 4

Antimicrobial activity of brevibacillin 2V brevibacillin against Staphylococcus aureus (MRSA) after exposure to human plasma. The starting concentration was 200 mg/L for both brevibacillin 2V and brevibacillin. Samples were collected at 0, 1, 2, 4, and 8 h, and 6 μl of each sample was loaded to a square plate containing S. aureus (MRSA). Bre 2V, brevibacillin 2V; Bre, brevibacillin.